REATA PHARMACEUTICALS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Reata Pharmaceuticals Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2023.
  • Reata Pharmaceuticals Inc Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2023 was $78.6M, a 39.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $78.6M -$50.6M -39.1% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $104M -$27.4M -20.9% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $105M -$21.5M -17% Dec 31, 2022 10-Q 2023-08-08
Q3 2022 $127M +$124M +4044% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $129M +$125M +3303% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $131M +$127M +2809% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $127M +$122M +2334% Dec 31, 2021 10-K 2023-02-24
Q3 2021 $3.07M +$1.9M +163% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $3.8M -$3.86M -50.4% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $4.51M -$3.86M -46.1% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $5.21M -$3.86M -42.6% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $1.17M -$7.1M -85.9% Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $7.65M -$1.33M -14.8% Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $8.37M Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $9.07M +$7.57M +505% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $8.26M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $8.98M Jun 30, 2019 10-Q 2019-08-08
Q4 2018 $1.5M Jan 1, 2019 10-K 2021-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.